Immucell Corp (ICCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Sales | 3,632 | 2,971 | 2,710 | 4,411 | 2,937 |
| Cost of Goods | 1,794 | 1,519 | 1,461 | 2,209 | 1,541 |
| Gross Profit | 1,838 | 1,451 | 1,249 | 2,202 | 1,396 |
| Operating Expenses | 2,874 | 2,400 | 2,257 | 2,145 | 2,863 |
| Operating Income | -243 | -430 | -547 | 265 | -926 |
| Other Income | -72 | -65 | -65 | -112 | -112 |
| Pre-tax Income | -314 | -495 | -612 | 154 | -1,038 |
| Income Tax | -4 | 7 | 15 | 9 | 15 |
| Net Income Continuous | -311 | -503 | -627 | 145 | -1,052 |
| Net Income | $-311 | $-503 | $-627 | $145 | $-1,052 |
| EPS Basic Total Ops | -0.06 | -0.07 | -0.09 | 0.03 | -0.18 |
| EPS Basic Continuous Ops | -0.06 | -0.07 | -0.09 | 0.03 | -0.19 |
| EPS Diluted Total Ops | -0.06 | -0.07 | -0.09 | 0.03 | -0.18 |
| EPS Diluted Continuous Ops | -0.06 | -0.07 | -0.09 | 0.03 | -0.19 |
| EBITDA(a) | $324 | $152 | $17 | $838 | $-354 |